Global Smart Syringes Market Research and Analysis, 2015-2021
MARKET INSIGHTS
Smart syringes The market is expected to grow at a CAGR of 10% from 2016-2021, owing to increasing number of diseases and infections transmitted due to improper and unsafe injection practices. Rising cases of chronic diseases and increasing geriatric population are also factors responsible for growth of Smart Syringes market. In addition, the WHO policy for worldwide shift to smart, self destructing syringes from traditional ones is the most important driving factor for the market. However, high costs of smart syringes and lack of awareness, especially in developing nations act as inhibiting factors for market growth. Moreover, large pharmaceutical companies have to incur high costs in order to adopt smart syringes, as they need to retool their supply chain of conventional syringes.
GEOGRAPHICAL INSIGHTS
North America is expected to dominate the market during the forecasted period attributed to high level of awareness about smart syringes and availability of sophisticated healthcare infrastructure in this region. However, APAC is estimated to be the fastest growing market owing to increasing healthcare expenditure and government initiatives to curb unsafe injection practices and prevent blood borne transmissions. Moreover, efforts by WHO and various governments together are also boosting market growth.
COMPETITIVE INSIGHTS
The key players in the global Smart Syringes market profiled in this report include Becton, Dickinson And Company, B. Braun Melsungen Ag, Baxter International Inc., Medtronic, Merck & Company Inc., Parker Hannifin, Retractable Technologies, Inc., Revolutions Medical Corporation, Smiths Group Plc, Star Syringe, Terumo Medical Corporation and Unilife Corporation.
Market segmentation
The market is segmented by product, applications, end users and geography. The market segmentation on the basis of product include active safety syringe, passive safety syringe and auto disable syringe. On the basis of applications, the market is segregated into drug delivery, vaccination and blood sample collection. Segmentation on the basis of end users include hospitals and clinics, physicians, diabetes patients, psychiatrists and others. The market is segmented on the basis of geography which includes North America, Europe, APAC and RoW.
OMR REPORT COVERS:
Smart syringes The market is expected to grow at a CAGR of 10% from 2016-2021, owing to increasing number of diseases and infections transmitted due to improper and unsafe injection practices. Rising cases of chronic diseases and increasing geriatric population are also factors responsible for growth of Smart Syringes market. In addition, the WHO policy for worldwide shift to smart, self destructing syringes from traditional ones is the most important driving factor for the market. However, high costs of smart syringes and lack of awareness, especially in developing nations act as inhibiting factors for market growth. Moreover, large pharmaceutical companies have to incur high costs in order to adopt smart syringes, as they need to retool their supply chain of conventional syringes.
GEOGRAPHICAL INSIGHTS
North America is expected to dominate the market during the forecasted period attributed to high level of awareness about smart syringes and availability of sophisticated healthcare infrastructure in this region. However, APAC is estimated to be the fastest growing market owing to increasing healthcare expenditure and government initiatives to curb unsafe injection practices and prevent blood borne transmissions. Moreover, efforts by WHO and various governments together are also boosting market growth.
COMPETITIVE INSIGHTS
The key players in the global Smart Syringes market profiled in this report include Becton, Dickinson And Company, B. Braun Melsungen Ag, Baxter International Inc., Medtronic, Merck & Company Inc., Parker Hannifin, Retractable Technologies, Inc., Revolutions Medical Corporation, Smiths Group Plc, Star Syringe, Terumo Medical Corporation and Unilife Corporation.
Market segmentation
The market is segmented by product, applications, end users and geography. The market segmentation on the basis of product include active safety syringe, passive safety syringe and auto disable syringe. On the basis of applications, the market is segregated into drug delivery, vaccination and blood sample collection. Segmentation on the basis of end users include hospitals and clinics, physicians, diabetes patients, psychiatrists and others. The market is segmented on the basis of geography which includes North America, Europe, APAC and RoW.
OMR REPORT COVERS:
- Comprehensive research methodology of Global Smart Syringes Market.
- This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst’s insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Global Smart Syringes Market.
- Insights about market determinants which are stimulating the Global Smart Syringes Market.
- Detailed and extensive market segments with regional distribution of forecasted revenues
- Extensive profiles and recent developments of market players
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. HISTORICAL ANALYSIS
2.3. CURRENT MARKET TRENDS
2.4. PIPELINE ANALYSIS
2.4.1. AUTO RETRACTABLE SMART SAFETY SYRINGE
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. DRUG AND DEVICE REGULATIONS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
3. MARKET DETERMINANTS
3.1. MOTIVATORS
3.1.1. INCREASING PREVALENCE OF BLOOD BORNE TRANSMISSIONS
3.1.2. INCREASE IN GERIATRIC POPULATION
3.1.3. GOVERNMENT INITIATIVES TO PREVENT IMPROPER AND UNSAFE INJECTION PRACTICES
3.1.4. WHO POLICY TO SHIFT TO SMART SYRINGES BY 2020
3.1.5. TECHNOLOGICAL ADVANCEMENTS
3.1.6. RISKS OF NEEDLE STICK INJURIES AND HOSPITAL ACQUIRED INFECTIONS
3.2. RESTRAINT
3.2.1. HIGH COSTS ASSOCIATED WITH SMART SYRINGES
3.2.2. LACK OF AWARENESS
3.2.3. COSTS INCURRED BY LARGE PHARMACEUTICAL COMPANIES IN RETOOLING SUPPLY CHAIN
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
3.3.2. INNOVATIONS IN INTRADERMAL INJECTIONS
4. MARKET SEGMENTATION
4.1. SMART SYRINGE BY PRODUCTS
4.1.1. ACTIVE SAFETY SYRINGE
4.1.2. PASSIVE SAFETY SYRINGE
4.1.3. AUTO-DISABLE
4.2. SMART SYRINGE
4.2.1. BLOOD SAMPLE COLLECTION
4.2.2. VACCINATION
4.2.3. DRUG DELIVERY
4.3. SMART SYRINGE BY END USER
4.3.1. HOSPITALS AND CLINICS
4.3.2. DIABETIC PATIENTS
4.3.3. PSYCHIATRISTS
4.3.4. PHYSICIANS
4.3.5. OTHERS END USER
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. GERMANY
6.2.3. FRANCE
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. ROAPAC
6.4. REST OF THE WORLD
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. HISTORICAL ANALYSIS
2.3. CURRENT MARKET TRENDS
2.4. PIPELINE ANALYSIS
2.4.1. AUTO RETRACTABLE SMART SAFETY SYRINGE
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. DRUG AND DEVICE REGULATIONS
2.6.1.1. UNITED STATES
2.6.1.2. EUROPEAN UNION
2.6.1.3. CHINA
2.6.1.4. INDIA
2.6.1.5. REST OF THE WORLD
3. MARKET DETERMINANTS
3.1. MOTIVATORS
3.1.1. INCREASING PREVALENCE OF BLOOD BORNE TRANSMISSIONS
3.1.2. INCREASE IN GERIATRIC POPULATION
3.1.3. GOVERNMENT INITIATIVES TO PREVENT IMPROPER AND UNSAFE INJECTION PRACTICES
3.1.4. WHO POLICY TO SHIFT TO SMART SYRINGES BY 2020
3.1.5. TECHNOLOGICAL ADVANCEMENTS
3.1.6. RISKS OF NEEDLE STICK INJURIES AND HOSPITAL ACQUIRED INFECTIONS
3.2. RESTRAINT
3.2.1. HIGH COSTS ASSOCIATED WITH SMART SYRINGES
3.2.2. LACK OF AWARENESS
3.2.3. COSTS INCURRED BY LARGE PHARMACEUTICAL COMPANIES IN RETOOLING SUPPLY CHAIN
3.3. OPPORTUNITY
3.3.1. EMERGING MARKETS
3.3.2. INNOVATIONS IN INTRADERMAL INJECTIONS
4. MARKET SEGMENTATION
4.1. SMART SYRINGE BY PRODUCTS
4.1.1. ACTIVE SAFETY SYRINGE
4.1.2. PASSIVE SAFETY SYRINGE
4.1.3. AUTO-DISABLE
4.2. SMART SYRINGE
4.2.1. BLOOD SAMPLE COLLECTION
4.2.2. VACCINATION
4.2.3. DRUG DELIVERY
4.3. SMART SYRINGE BY END USER
4.3.1. HOSPITALS AND CLINICS
4.3.2. DIABETIC PATIENTS
4.3.3. PSYCHIATRISTS
4.3.4. PHYSICIANS
4.3.5. OTHERS END USER
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. GERMANY
6.2.3. FRANCE
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. ROAPAC
6.4. REST OF THE WORLD
LIST OF TABLES
TABLE # 1 GLOBAL SMART SYRINGE MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2015–2021 ($ MILLION)
TABLE # 2 GLOBAL ACTIVE SAFETY SYRINGE MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 3 GLOBAL PASSIVE SAFETY SYRINGE MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 4 GLOBAL AUTO-DISABLE SYRINGE MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 5 GLOBAL SMART SYRINGE MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021 ($ MILLION)
TABLE # 6 GLOBAL BLOOD SAMPLE COLLECTION MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 7 GLOBAL VACCINATION MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 8 GLOBAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 9 GLOBAL SMART SYRINGE MARKET RESEARCH AND ANALYSIS, BY END USER, 2015-2021 ($ MILLION)
TABLE # 10 GLOBAL HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 11 GLOBAL DIABETIC PATIENTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 12 GLOBAL PSYCHIATRISTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 13 GLOBAL PHYSICIANS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 14 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 15 B. BRAUN MELSUNGEN PRODUCT PORTFOLIO
TABLE # 16 B. BRAUN MELSUNGEN RECENT ACTIVITIES
TABLE # 17 B. BRAUN MELSUNGEN SWOT ANALYSIS
TABLE # 18 BAXTER INTERNATIONAL INC. PRODUCT PORTFOLIO
TABLE # 19 BAXTER INTERNATIONAL INC. RECENT ACTIVITIES
TABLE # 20 BAXTER INTERNATIONAL INC. SWOT ANALYSIS
TABLE # 21 BECTON DICKINSON INC. PRODUCT PORTFOLIO
TABLE # 22 BECTON DICKINSON INC. RECENT ACTIVITIES
TABLE # 23 BECTON DICKINSON INC. SWOT ANALYSIS
TABLE # 24 MEDTRONIC PRODUCT PORTFOLIO
TABLE # 25 MEDTRONIC RECENT ACTIVITIES
TABLE # 26 MEDTRONIC SWOT ANALYSIS
TABLE # 27 MERCK & COMPANY INC. PRODUCT PORTFOLIO
TABLE # 28 MERCK & COMPANY INC. RECENT ACTIVITIES
TABLE # 29 MERCK & COMPANY INC. SWOT ANALYSIS
TABLE # 30 PARKER HANNIFIN PRODUCT PORTFOLIO
TABLE # 31 PARKER HANNIFIN RECENT ACTIVITIES
TABLE # 32 PARKER HANNIFIN SWOT ANALYSIS
TABLE # 33 RETRACTABLE TECHNOLOGIES, INC. PRODUCT PORTFOLIO
TABLE # 34 RETRACTABLE TECHNOLOGIES, INC. RECENT ACTIVITIES
TABLE # 35 RETRACTABLE TECHNOLOGIES, INC. SWOT ANALYSIS
TABLE # 36 REVOLUTIONS MEDICAL CORPORATION PRODUCT PORTFOLIO
TABLE # 37 REVOLUTIONS MEDICAL CORPORATION RECENT ACTIVITIES
TABLE # 38 REVOLUTIONS MEDICAL CORPORATION SWOT ANALYSIS
TABLE # 39 SMITHS GROUP PLC PRODUCT PORTFOLIO
TABLE # 40 SMITHS GROUP PLC RECENT ACTIVITIES
TABLE # 41 SMITHS GROUP PLC SWOT ANALYSIS
TABLE # 42 STAR SYRINGE PRODUCT PORTFOLIO
TABLE # 43 STAR SYRINGE RECENT ACTIVITIES
TABLE # 44 STAR SYRINGE SWOT ANALYSIS
TABLE # 45 TERUMO MEDICAL CORPORATION PRODUCT PORTFOLIO
TABLE # 46 TERUMO MEDICAL CORPORATION RECENT ACTIVITIES
TABLE # 47 TERUMO MEDICAL CORPORATION SWOT ANALYSIS
TABLE # 48 UNILIFE CORPORATION PRODUCT PORTFOLIO
TABLE # 49 UNILIFE CORPORATION RECENT ACTIVITIES
TABLE # 50 UNILIFE CORPORATION SWOT ANALYSIS
TABLE # 1 GLOBAL SMART SYRINGE MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2015–2021 ($ MILLION)
TABLE # 2 GLOBAL ACTIVE SAFETY SYRINGE MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 3 GLOBAL PASSIVE SAFETY SYRINGE MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 4 GLOBAL AUTO-DISABLE SYRINGE MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 5 GLOBAL SMART SYRINGE MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2015-2021 ($ MILLION)
TABLE # 6 GLOBAL BLOOD SAMPLE COLLECTION MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 7 GLOBAL VACCINATION MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 8 GLOBAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 9 GLOBAL SMART SYRINGE MARKET RESEARCH AND ANALYSIS, BY END USER, 2015-2021 ($ MILLION)
TABLE # 10 GLOBAL HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 11 GLOBAL DIABETIC PATIENTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 12 GLOBAL PSYCHIATRISTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 13 GLOBAL PHYSICIANS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 14 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 15 B. BRAUN MELSUNGEN PRODUCT PORTFOLIO
TABLE # 16 B. BRAUN MELSUNGEN RECENT ACTIVITIES
TABLE # 17 B. BRAUN MELSUNGEN SWOT ANALYSIS
TABLE # 18 BAXTER INTERNATIONAL INC. PRODUCT PORTFOLIO
TABLE # 19 BAXTER INTERNATIONAL INC. RECENT ACTIVITIES
TABLE # 20 BAXTER INTERNATIONAL INC. SWOT ANALYSIS
TABLE # 21 BECTON DICKINSON INC. PRODUCT PORTFOLIO
TABLE # 22 BECTON DICKINSON INC. RECENT ACTIVITIES
TABLE # 23 BECTON DICKINSON INC. SWOT ANALYSIS
TABLE # 24 MEDTRONIC PRODUCT PORTFOLIO
TABLE # 25 MEDTRONIC RECENT ACTIVITIES
TABLE # 26 MEDTRONIC SWOT ANALYSIS
TABLE # 27 MERCK & COMPANY INC. PRODUCT PORTFOLIO
TABLE # 28 MERCK & COMPANY INC. RECENT ACTIVITIES
TABLE # 29 MERCK & COMPANY INC. SWOT ANALYSIS
TABLE # 30 PARKER HANNIFIN PRODUCT PORTFOLIO
TABLE # 31 PARKER HANNIFIN RECENT ACTIVITIES
TABLE # 32 PARKER HANNIFIN SWOT ANALYSIS
TABLE # 33 RETRACTABLE TECHNOLOGIES, INC. PRODUCT PORTFOLIO
TABLE # 34 RETRACTABLE TECHNOLOGIES, INC. RECENT ACTIVITIES
TABLE # 35 RETRACTABLE TECHNOLOGIES, INC. SWOT ANALYSIS
TABLE # 36 REVOLUTIONS MEDICAL CORPORATION PRODUCT PORTFOLIO
TABLE # 37 REVOLUTIONS MEDICAL CORPORATION RECENT ACTIVITIES
TABLE # 38 REVOLUTIONS MEDICAL CORPORATION SWOT ANALYSIS
TABLE # 39 SMITHS GROUP PLC PRODUCT PORTFOLIO
TABLE # 40 SMITHS GROUP PLC RECENT ACTIVITIES
TABLE # 41 SMITHS GROUP PLC SWOT ANALYSIS
TABLE # 42 STAR SYRINGE PRODUCT PORTFOLIO
TABLE # 43 STAR SYRINGE RECENT ACTIVITIES
TABLE # 44 STAR SYRINGE SWOT ANALYSIS
TABLE # 45 TERUMO MEDICAL CORPORATION PRODUCT PORTFOLIO
TABLE # 46 TERUMO MEDICAL CORPORATION RECENT ACTIVITIES
TABLE # 47 TERUMO MEDICAL CORPORATION SWOT ANALYSIS
TABLE # 48 UNILIFE CORPORATION PRODUCT PORTFOLIO
TABLE # 49 UNILIFE CORPORATION RECENT ACTIVITIES
TABLE # 50 UNILIFE CORPORATION SWOT ANALYSIS
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
7. COMPANY PROFILES
7.1. B. BRAUN MELSUNGEN
7.1.1. INTRODUCTION
7.1.2. B. BRAUN MELSUNGEN PRODUCT PORTFOLIO
7.1.3. B. BRAUN MELSUNGEN RECENT ACTIVITIES
7.1.4. B. BRAUN MELSUNGEN SWOT ANALYSIS
7.2. BAXTER INTERNATIONAL INC.
7.2.1. INTRODUCTION
7.2.2. BAXTER INTERNATIONAL INC. PRODUCT PORTFOLIO
7.2.3. BAXTER INTERNATIONAL INC. RECENT ACTIVITIES
7.2.4. BAXTER INTERNATIONAL INC. SWOT ANALYSIS
7.3. BECTON DICKINSON INC.
7.3.1. INTRODUCTION
7.3.2. BECTON DICKINSON INC. PRODUCT PORTFOLIO
7.3.3. BECTON DICKINSON INC. RECENT ACTIVITIES
7.3.4. BECTON DICKINSON INC. SWOT ANALYSIS
7.4. MEDTRONIC
7.4.1. INTRODUCTION
7.4.2. MEDTRONIC PRODUCT PORTFOLIO
7.4.3. MEDTRONIC RECENT ACTIVITIES
7.4.4. MEDTRONIC SWOT ANALYSIS
7.5. MERCK & COMPANY INC.
7.5.1. INTRODUCTION
7.5.2. MERCK & COMPANY INC. PRODUCT PORTFOLIO
7.5.3. MERCK & COMPANY INC. RECENT ACTIVITIES
7.5.4. MERCK & COMPANY INC. SWOT ANALYSIS
7.6. PARKER HANNIFIN
7.6.1. INTRODUCTION
7.6.2. PARKER HANNIFIN PRODUCT PORTFOLIO
7.6.3. PARKER HANNIFIN RECENT ACTIVITIES
7.6.4. PARKER HANNIFIN SWOT ANALYSIS
7.7. RETRACTABLE TECHNOLOGIES, INC.
7.7.1. INTRODUCTION
7.7.2. RETRACTABLE TECHNOLOGIES, INC. PRODUCT PORTFOLIO
7.7.3. RETRACTABLE TECHNOLOGIES, INC. RECENT ACTIVITIES
7.7.4. RETRACTABLE TECHNOLOGIES, INC. SWOT ANALYSIS
7.8. REVOLUTIONS MEDICAL CORPORATION
7.8.1. INTRODUCTION
7.8.2. REVOLUTIONS MEDICAL CORPORATION PRODUCT PORTFOLIO
7.8.3. REVOLUTIONS MEDICAL CORPORATION RECENT ACTIVITIES
7.8.4. REVOLUTIONS MEDICAL CORPORATION SWOT ANALYSIS
7.9. SMITHS GROUP PLC
7.9.1. INTRODUCTION
7.9.2. SMITHS GROUP PLC PRODUCT PORTFOLIO
7.9.3. SMITHS GROUP PLC RECENT ACTIVITIES
7.9.4. SMITHS GROUP PLC SWOT ANALYSIS
7.10. STAR SYRINGE
7.10.1. INTRODUCTION
7.10.2. STAR SYRINGE PRODUCT PORTFOLIO
7.10.3. STAR SYRINGE RECENT ACTIVITIES
7.10.4. STAR SYRINGE SWOT ANALYSIS
7.11. TERUMO MEDICAL CORPORATION
7.11.1. INTRODUCTION
7.11.2. TERUMO MEDICAL CORPORATION PRODUCT PORTFOLIO
7.11.3. TERUMO MEDICAL CORPORATION RECENT ACTIVITIES
7.11.4. TERUMO MEDICAL CORPORATION SWOT ANALYSIS
7.12. UNILIFE CORPORATION
7.12.1. INTRODUCTION
7.12.2. UNILIFE CORPORATION PRODUCT PORTFOLIO
7.12.3. UNILIFE CORPORATION RECENT ACTIVITIES
7.12.4. UNILIFE CORPORATION SWOT ANALYSIS
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
7. COMPANY PROFILES
7.1. B. BRAUN MELSUNGEN
7.1.1. INTRODUCTION
7.1.2. B. BRAUN MELSUNGEN PRODUCT PORTFOLIO
7.1.3. B. BRAUN MELSUNGEN RECENT ACTIVITIES
7.1.4. B. BRAUN MELSUNGEN SWOT ANALYSIS
7.2. BAXTER INTERNATIONAL INC.
7.2.1. INTRODUCTION
7.2.2. BAXTER INTERNATIONAL INC. PRODUCT PORTFOLIO
7.2.3. BAXTER INTERNATIONAL INC. RECENT ACTIVITIES
7.2.4. BAXTER INTERNATIONAL INC. SWOT ANALYSIS
7.3. BECTON DICKINSON INC.
7.3.1. INTRODUCTION
7.3.2. BECTON DICKINSON INC. PRODUCT PORTFOLIO
7.3.3. BECTON DICKINSON INC. RECENT ACTIVITIES
7.3.4. BECTON DICKINSON INC. SWOT ANALYSIS
7.4. MEDTRONIC
7.4.1. INTRODUCTION
7.4.2. MEDTRONIC PRODUCT PORTFOLIO
7.4.3. MEDTRONIC RECENT ACTIVITIES
7.4.4. MEDTRONIC SWOT ANALYSIS
7.5. MERCK & COMPANY INC.
7.5.1. INTRODUCTION
7.5.2. MERCK & COMPANY INC. PRODUCT PORTFOLIO
7.5.3. MERCK & COMPANY INC. RECENT ACTIVITIES
7.5.4. MERCK & COMPANY INC. SWOT ANALYSIS
7.6. PARKER HANNIFIN
7.6.1. INTRODUCTION
7.6.2. PARKER HANNIFIN PRODUCT PORTFOLIO
7.6.3. PARKER HANNIFIN RECENT ACTIVITIES
7.6.4. PARKER HANNIFIN SWOT ANALYSIS
7.7. RETRACTABLE TECHNOLOGIES, INC.
7.7.1. INTRODUCTION
7.7.2. RETRACTABLE TECHNOLOGIES, INC. PRODUCT PORTFOLIO
7.7.3. RETRACTABLE TECHNOLOGIES, INC. RECENT ACTIVITIES
7.7.4. RETRACTABLE TECHNOLOGIES, INC. SWOT ANALYSIS
7.8. REVOLUTIONS MEDICAL CORPORATION
7.8.1. INTRODUCTION
7.8.2. REVOLUTIONS MEDICAL CORPORATION PRODUCT PORTFOLIO
7.8.3. REVOLUTIONS MEDICAL CORPORATION RECENT ACTIVITIES
7.8.4. REVOLUTIONS MEDICAL CORPORATION SWOT ANALYSIS
7.9. SMITHS GROUP PLC
7.9.1. INTRODUCTION
7.9.2. SMITHS GROUP PLC PRODUCT PORTFOLIO
7.9.3. SMITHS GROUP PLC RECENT ACTIVITIES
7.9.4. SMITHS GROUP PLC SWOT ANALYSIS
7.10. STAR SYRINGE
7.10.1. INTRODUCTION
7.10.2. STAR SYRINGE PRODUCT PORTFOLIO
7.10.3. STAR SYRINGE RECENT ACTIVITIES
7.10.4. STAR SYRINGE SWOT ANALYSIS
7.11. TERUMO MEDICAL CORPORATION
7.11.1. INTRODUCTION
7.11.2. TERUMO MEDICAL CORPORATION PRODUCT PORTFOLIO
7.11.3. TERUMO MEDICAL CORPORATION RECENT ACTIVITIES
7.11.4. TERUMO MEDICAL CORPORATION SWOT ANALYSIS
7.12. UNILIFE CORPORATION
7.12.1. INTRODUCTION
7.12.2. UNILIFE CORPORATION PRODUCT PORTFOLIO
7.12.3. UNILIFE CORPORATION RECENT ACTIVITIES
7.12.4. UNILIFE CORPORATION SWOT ANALYSIS
